DNA origami successfully used to kill leukaemia cells
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
List view / Grid view
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
23 February 2016 | By Victoria White
In a highly relevant non-human primate model TYG100 was able to induce a strong and clinically relevant immune response...
23 February 2016 | By Victoria White
Plasticell and Pierre Fabre are to work together to discover plant-based products that enhance the metabolic function of brown adipose tissue...
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
22 February 2016 | By Katie Sadler
Pherecydes Pharma has announced the appointment of Guy-Charles Fanneau de La Horie, MBA as its new Chief Executive Officer.
19 February 2016 | By Victoria White
The discovery could change the way researchers understand and treat autoimmune diseases such as type 1 diabetes and multiple sclerosis...
19 February 2016 | By Victoria White
In a study, mice with spinal muscular atrophy saw great improvement when the JNK3 enzyme was genetically inhibited to eliminate its activity...
19 February 2016 | By Victoria White
Researchers have developed a new nanoparticle that uses a tumour cell's protective mechanism against itself - short-circuiting tumour cell metabolism and killing tumour cells...
18 February 2016 | By Select Biosciences
Select Biosciences is organizing its 2nd Annual World Congress focusing on Organs-on-Chips—an extremely important and cutting-edge field of important in basic research as well as pharmaceutical discovery and development...
18 February 2016 | By SELECTBIO
SELECTBIO is delighted to announce Organ-on-a-Chip Europe 2016, which will be held on 5 - 6 April in Cambridge, UK...
18 February 2016 | By Victoria White
The treatment - an antibody that blocks the MERS virus - was produced by cows that had been genetically modified to mimic certain aspects of the human immune system...
18 February 2016 | By Victoria White
The results demonstrate that suppression of NR2F6 in T-cells results in increased expression of key immune stimulatory proteins IL-17 and IL-18...
17 February 2016 | By Victoria White
Cryptococcus neoformans is a fungus that causes fatal infections in humans with a weakened immune system...
17 February 2016 | By Victoria White
In preclinical studies, Inovio's Zika DNA vaccine resulted in seroconversion, or the development of detectable specific antibodies in the blood...
17 February 2016 | By Victoria White
The small peptide has been shown to be an effective at shuttling functional proteins into the spinal cord after a muscle injection...